Everything you need to know about What Predicts TMS Success? Key Factors That Influence Treatment Outcomes — how it works, what it costs, and how to find a provider who actually knows what they're doing.
The TMS Patient Buyer's Guide
Everything to know before your first consult — questions to ask, what to expect, and how to compare providers.
Transcranial magnetic stimulation offers hope for many patients with depression who have not found relief through medications or therapy. However, TMS is not effective for everyone. Understanding the factors that predict treatment response can help patients and clinicians set realistic expectations, optimize treatment protocols, and make informed decisions about whether TMS is appropriate.
Treatment Response Rates: Setting the Baseline
Before examining predictors, it helps to understand the overall picture. Published response rates for TMS in treatment-resistant depression range from roughly 30% in sham-controlled trials to about 50-60% in real-world clinical studies, with remission in roughly 15-35% depending on the study (for example, Carpenter et al., Depression and Anxiety, 2012; George et al., Archives of General Psychiatry, 2010). Many patients do not respond adequately to a first course.
Individual outcomes vary widely. What predicts who responds is the focus of active research, and no predictor is reliable enough to decide on its own whether TMS is worth trying.
What You’ll Learn
- What research says about age, treatment resistance level, and episode duration
- What research on brain connectivity patterns suggests
- How comorbidities may affect TMS effectiveness
- How coil type, stimulation frequency, and neuronavigation affect outcomes
- What patients can do to optimize their chances of success
Patient Characteristics That Predict Response
Age
Findings on age are mixed. Some analyses have found somewhat lower response in older adults, while other studies, including large real-world datasets, have found response in older adults similar to that in younger adults. Age alone should not disqualify someone from treatment.
Duration of Current Episode
Some studies associate a longer current episode with lower response, but findings are not consistent and many people with long episodes still respond.
Number of Failed Medication Trials
TMS was originally studied in treatment-resistant depression. Some studies, including a large trial in which response was lower in people with greater treatment resistance, suggest that people who have failed fewer medication trials may respond somewhat better, though TMS can help people with extensive treatment histories as well.
Brain Connectivity Patterns
Neuroimaging research has reported that pre-treatment brain connectivity patterns, such as the connectivity of the stimulation site to the subgenual cingulate, may be associated with response to TMS. These findings come from research studies, are not consistent across datasets, and are not yet used to decide who gets treated in routine clinical practice. Connectivity-guided targeting, including the approach used in Stanford’s SNT protocol, is an active area of research.
Comorbid Conditions
Researchers have studied whether certain conditions, such as personality disorders, active substance use, or significant cognitive impairment, are associated with a different response to TMS. Evidence is limited. TMS is not appropriate for some presentations (for example, depression with psychotic features without appropriate psychiatric care), and your clinician will screen for these.
Genetic Factors
Researchers have studied genetic variants, including BDNF Val66Met, as possible predictors of TMS response. Results are inconsistent, and genetic testing is not used to guide TMS treatment.
Treatment Parameters That Affect Outcomes
Coil Type
Different coil geometries produce different stimulation patterns. Figure-8 coils provide focal stimulation of the DLPFC and are the most common. H-coils (BrainsWay Deep TMS) are FDA-cleared for depression and reach deeper and broader regions with less focality. Whether one coil type produces better outcomes for a given patient has not been established.
Stimulation Frequency and Pattern
- Standard high-frequency (10 Hz) — The most established protocol for left DLPFC stimulation
- Theta burst (iTBS) — Much shorter sessions; a large randomized trial found it non-inferior to standard 10 Hz rTMS for depression (Blumberger et al., The Lancet, 2018)
- Low-frequency (1 Hz) right-sided and bilateral stimulation — Used in some protocols; evidence on which patients benefit is limited
Treatment Intensity and Dose
Standard protocols deliver stimulation at about 120% of motor threshold, for about 30-36 sessions. Accelerated protocols such as SNT/SAINT deliver multiple sessions per day and reported high remission rates in a small randomized trial (about 79% vs. 13% with sham in 29 patients; Cole et al., American Journal of Psychiatry, 2022), though it is not clear which components account for the effect.
Neuronavigation
Using MRI guidance to target stimulation sites improves accuracy. Whether this improves outcomes in routine care is still being studied.
What Patients Can Do to Improve Their Chances
While some predictors are fixed, patients can optimize their treatment:
- Choose an experienced provider who follows labeled protocols and monitors your progress
- Ask about dosing — your dose should be calibrated to your motor threshold and adjusted for tolerability
- Complete the full course — stopping early reduces the total dose you receive
- Review concurrent medications with your provider
- Consider psychotherapy alongside TMS; it is a standard part of depression care
- Address sleep and lifestyle — regular sleep and exercise support recovery from depression
Realistic Expectations
Understanding what affects TMS success helps set appropriate expectations. TMS is:
- An FDA-cleared option for people whose depression has not responded to antidepressant medication
- Not a cure — relapse can occur and some patients need further treatment
- Variable — outcomes range from complete remission to no benefit
- Worth discussing — even partial response can meaningfully improve quality of life for some people
If you are considering TMS, discuss these predictive factors with your provider. A thorough evaluation should include assessment of your specific risk profile and optimization of treatment parameters for your individual situation.
Frequently Asked Questions
Does age affect TMS treatment response?
Findings are mixed. Some analyses have found somewhat lower response in older adults, while other studies have found similar response across ages. Age alone should not disqualify someone from treatment.
How does brain connectivity predict TMS response?
Research studies have reported associations between pre-treatment brain connectivity and TMS response, but findings are not consistent and connectivity measures are not yet used to decide who gets treated in routine practice. Connectivity-guided targeting is an active area of research.
Can I improve my TMS success rate?
You can discuss these with your clinician: choose an experienced provider, ask about dosing, complete the full course, review concurrent medications, consider psychotherapy during TMS, and support sleep and exercise.
Ready to Explore Your TMS Options?
Browse verified TMS providers, read real reviews, and find the right treatment for your situation.
Related reading
- TMS for Multiple Sclerosis: Addressing Fatigue, Depression, and Cognitive Impairment
- What TMS Actually Feels Like: A Session-by-Session Guide
- How to Prepare for Your First TMS Session
- Preparing for Your First TMS Session: A Practical Walkthrough
- TMS for anxiety
- TMS for Treatment-Resistant Depression: What Patients Need to Know
